Mitochondria have been classically characterized as organelles with responsibility for cellular energy production in the form of ATP, but they are also the organelles through which apoptotic signaling occurs. Cell stress stimuli can result in outer membrane permeabilization, after which mitochondria release numerous proteins involved in apoptotic signaling, including cytochrome c, apoptosis-inducing factor, endonuclease G, Smac/DIABLO and Omi/HtrA2. Cell fate is determined by signaling through apoptotic proteins within the Bcl-2 (B-cell lymphoma 2) protein family, which converges on mitochondria. Many cancerous cells display abnormal levels of Bcl-2 protein family member expression that results in defective apoptotic signaling. Alterations in bioenergetic function also contribute to cancer as well as numerous other disorders. Recent evidence indicates that several pro-apoptotic proteins localized within mitochondria, as well as proteins within the Bcl-2 protein family, can influence mitochondrial bioenergetic function. This review focuses on the emerging roles of these proteins in the control of mitochondrial activity.
INTRODUCTION
Mitochondria are vital organelles required by most normal cell types, canonically defined as being the primary contributor to the intracellular adenosine triphosphate (ATP) pool by the process of oxidative phosphorylation (OXPHOS). They are structurally characterized by four compartments, a mitochondrial matrix, a convoluted inner membrane, an intermembrane space and an outer membrane ( Figure 1 ). The enzymes of the tricarboxylic acid cycle, located within the mitochondrial matrix, generate the substrates required to fuel OXPHOS of adenosine diphosphate (ADP) by the enzymes of the electron transport chain (ETC), located on the mitochondrial inner membrane. The enzymes of tricarboxylic acid cycle, located within the mitochondrial matrix, are fueled by acetyl coenzyme A. The pyruvate dehydrogenase complex converts pyruvate derived from glycolysis into acetyl coenzyme A, and mitochondria also derive acetyl coenzyme A from fatty acids by b-oxidation within the mitochondrial matrix. Abnormalities in metabolic pathways are common in malignant cell types, with most cancer cells using aerobic glycolysis for ATP production to a much greater extent than nontransformed cells. Although this phenomenon, termed 'the Warburg effect', is not fully understood, it has been proposed that the adaptation facilitates nutrient incorporation into the biomass (such as nucleotides, amino acids and lipids) required for cell division. 1 Indeed, it was recently demonstrated that reversal of the enzymes of the tricarboxylic acid cycle occurs under hypoxic conditions 2 or where ETC enzyme activity is defective, 3 promoting fatty acid synthesis in tumor cells.
Intracellular ATP is generated most efficiently by OXPHOS. OXPHOS uses a proton circuit, whereby the ETC enzymes pump protons out of the matrix, creating an electrochemical gradient or proton motive force, the electrical component of which is termed the mitochondrial membrane potential (Dcm). Protons then re-enter the mitochondrial matrix through the ATP synthase, a rotary nanomotor that uses the proton motive force to combine a phosphate group and an ADP molecule into ATP within in the matrix. 4 The Dcm can also be affected by proton leak through the mitochondrial inner membrane into the matrix or by the activity of uncoupling proteins, which act to uncouple the processes of oxygen consumption and ATP production from each other. 5 The proton motive force also enables mitochondria to maintain intracellular ion homeostasis, with particularly important roles in Ca 2 þ and Na þ sequestering. 6 Among the molecules that govern mitochondrial ion transport are the outer membrane voltagedependent anion channel (VDAC), and the inner membrane Ca 2 þ uniporter, Ca 2 þ /H þ exchanger and Na þ /H þ exchanger. VDAC also governs transport of metabolites of up to 5 kDa (including ATP and ADP) across the mitochondrial outer membrane, 7 whereas exchange of ATP and ADP between the matrix and the intermembrane space is carried out by the adenine nucleotide translocator (ANT).
Mitochondria are also the primary site of intracellular reactive oxygen species (ROS) production, as an unavoidable generation of ROS occurs during the process of electron transfer by ETC enzymes. 8 ROS generated include both oxygen-containing molecules that extract electrons indiscriminately to fill their outer orbital shell (termed 'free radicals') and molecules that are unstable in the presence of transition metals (such as H 2 O 2 ). The most commonly generated within mitochondria include superoxide (O 2 -), hydrogen peroxide (H 2 O 2 ) and hydroxyl radicals (OH). ROS generation within mitochondria occurs when electrons are transferred directly to oxygen by the redox intermediaries, in particular complex I, which releases ROS into the mitochondrial matrix, and complex III, which releases ROS into both the matrix and the intermembrane space. 9 Other sites of significant mitochondrial ROS production include the reduced ubiquinol pool within the ETC 10 and monoamine oxidase, an enzyme tightly associated with mitochondrial outer membrane and found in most mammalian tissues, which generates H 2 O 2 when catalyzing deamination of monoamies such as 5-hydroxytryptamine (or serotonin), histamine, dopamine, noradrenaline and adrenaline.
11
Although excessive ROS production is known to cause oxidative damage and has been shown to induce cell death, 12 there is an increasing body of evidence suggesting that low level of ROS production is involved in survival and proliferation signaling in cancer cells. 13, 14 In recent years, mitochondrial biology has enjoyed a resurgence toward the forefront of biomedical research fields. This is because of the discovery that mitochondria are also critically important in programmed cell death signaling pathways. It has emerged that apoptotic signaling proteins converge on the mitochondria, and following exposure to excessive levels of cell stress, mitochondria can initiate or amplify cell death signaling, committing the fate of the cell to suicide in a process termed the 'intrinsic apoptotic pathway' or 'mitochondrial apoptosis'. [15] [16] [17] Among the many cell stress signals known to trigger the intrinsic apoptotic pathway are DNA damage, withdrawal of trophic support and endoplasmic reticulum (ER) stress. These stress pathways are activated by current chemotherapeutics as well as radiation therapy. Defects in the mitochondrial apoptotic pathway have the potential to confer a survival advantage to cancer cells, contributing to the resistance of cancer cells to chemotherapy and radiotherapy. 18 The signals that exert the greatest control over the mitochondrial apoptosis pathway are proteins within the Bcl-2 (B-cell lymphoma 2) family. 15, 19 Two multidomain proteins within this family, Bax (Bcl-2 associated protein X) and Bak, are pro-apoptotic proteins that have been shown to be required for the activation of this pathway. 20 Activated Bax and Bak homo-oligomerize on the mitochondrial outer membrane when activated, resulting in mitochondrial outer membrane permeabilization (MOMP), after which pro-apoptotic factors are released. Monomeric activated Bax and Bak can be sequestered by a number of multidomain antiapoptotic proteins within the Bcl-2 family, which are localized to mitochondria and the ER. Among these are Bcl-2 itself, Bcl-x L (B-cell lymphoma-extra large), Mcl-1 (myeloid cell leukemia-1), Bcl-w and Bfl-1. 21 The anti-apoptotic function of these proteins may be antagonized by a third set of proteins within the Bcl-2 family, the BH3-only proteins. These proteins all possess a BH-3 (Bcl-2 homology 3) region, which is required for their proapoptotic function. BH3-only proteins can be activated by transcription or posttranslational modification in response to damage. At least two BH3-only proteins, Bim and Bid, and possibly other BH3-only proteins such as PUMA (p53 upregulated modulator of apoptosis), can also interact with anti-apoptotic Bcl-2 family members and can also directly activate Bax and Bak. Other BH-3-only proteins such as Bmf, Bad, Noxa and Hrk preferably interact with anti-apoptotic Bcl-2 family members with various and distinctive affinities. 16, 22 Increased mitochondrial susceptibility to BH3 proteins in tumor cells is thought to be the foremost reason as to why they selectively respond to cytotoxic chemotherapy. 23 Thus, treatment with BH3 mimetics may prove to be a fruitful field for the development of novel chemotherapeutics with less toxic side effects on noncancerous tissue. Furthermore, chemosensitivity in multiple myeloma, acute myeloid leukemia and acute, lymphocytic leukemia and ovarian cancer was found to correlate with pretreatment mitochondrial susceptibility to BH3 peptides Puma and Bmf, 23 suggesting that the balance of Bcl-2 family members in malignant cells is a key determinant of clinical outcome in these types of cancer.
Another subject of scrutiny in the field of cancer research in recent years is signaling through AMP-activated protein kinase (AMPK), an evolutionary conserved intracellular sensor of bioenergetic stress. AMPK is activated by an increase in the AMP/ATP ratio and when activated promotes catabolic processes such as fatty acid oxidation and glucose uptake. 24, 25 The downstream effects of AMPK activation have not been fully elucidated, and although recent reports suggest that AMPK activation promotes tumor cell survival under conditions of energy stress, [26] [27] [28] prolonged AMPK activation has also been shown to induce expression of proapoptotic BH3 proteins. 29, 30 There is evidence indicating that pharmacological activation of AMPK may have therapeutic potential in cancer, primarily the observation by multiple groups that the incidence of cancer is reduced in patients treated with metformin, an antidiabetic drug known to activate AMPK. 31 Figure 1 . Mitochondrial processes involved in cell survival (left) and death signaling (right). The enzymes of the tricarboxylic acid (TCA) cycle are located within the mitochondrial matrix, and fuel OXPHOS of ADP to generate ATP. OXPHOS is carried out by the enzymes of the ETC (complexes I-V). Complexes I, III and IV generate the Dcm by producing an electochemical gradient of protons across the mitochondrial inner membrane. The energy of Dcm is harnessed by complex V of the chain to combine ADP and inoganic phosphate (Pi) to produce ATP. ATP/ADP exchange between mitochondria and the cytoplasm occurs through the VDAC on the outer membrane, and the ANT catalyzes exchange between the matrix and intermembrane space. Pi is symported into the matrix with H þ in a process driven by Dcm. The Dcm also drives Ca 2 þ ion uptake by the calcium uniporter, and antiport of Na þ and Ca 2 þ occurs via the Na þ /Ca 2 þ exchanger. Mitochondria can also amplify apoptotic signaling, which is controlled by the Bcl-2 family proteins. Signaling by pro-and anti-apoptotic members of this family converge on the mitochondrial outer membrane, and can induce pore formation involving Bax and Bak oligomerization, resulting in MOMP. Following MOMP, pro-apoptotic factors such as cyt c, endoG, AIF, Smac/DIABLO and Omi cross the outer membrane through the pore, inducing apoptosis by caspase activation and DNA fragmentation. The loss of cyt c from the intermembrane space under these circumstances is sufficient to diminish the capacity of OXPHOS to the extent that Dcm collapses. ROS generated by the process of OXPHOS can contribute to cell death, as can excess intramitochondrial Ca 2 þ , by inducing mPT. mPT pore formation allows influx of H 2 O and solutes from the cytoplasm into the matrix, resulting in mitochondrial swelling and rupture of the outer membrane, releasing all intramitochondrial contents, including the aforementioned pro-apoptotic factors.
Under certain circumstances, mitochondria may undergo a distinct form of permeabilization, termed mitochondrial 'permeability transition' (mPT), which also leads to cell death. 33 Prolonged elevated cytoplasmic Ca 2 þ concentration can result in excessive Ca 2 þ influx into the mitochondrial matrix to cause formation of a complex involving the cyclophilin D (cypD), VDAC and the ANT (Figure 1 ). The complex forms a pore that spans the inner and outer membranes, allowing influx of H 2 O, ions and small molecules of up to 1500 kDa in size, causing swelling of the matrix that eventually leads to rupture of both inner and outer membranes and release of mitochondrial pro-apoptotic factors. ROS formation, misfolding of proteins within the mitochondrial matrix and ER stress have been implicated in mPT-induced cell death, but the process has been most closely associated with excessive influx of extracellular Ca 2 þ 34 and ischemia/reperfusion injury. 35 However, the mechanisms underlying the initiation of pore formation, as well as the exact structure of the pore, remain incompletely defined. mPT can still occur in the absence of ANT 36 and cypD knockout mice show no developmental abnormalities. 37 Dissociation of cypD from ANT is induced by sirtuin-3, a histone deacetylase localized to the mitochondrial matrix. 38 Interestingly, inactivation of cypD by sirtuin-3-mediated deacetylation also triggers detachment of the glycolytic enzyme hexokinase II from mitochondria. 38 Binding of hexokinase II to VDAC is increased in many cancer cells, and is thought to contribute to the accelerated rate of glycolysis. 39 Indeed, increased hexokinase localization at mitochondria has been suggested to protect against cell death and has thus been associated with cancer cell resistance to cytotoxicity. 40 Although both pro-and anti-apoptotic Bcl-2 family proteins have also been shown to interact with mPT components, [41] [42] [43] mPT-induced cell death is generally considered to be necrotic rather than apoptotic. 37, 44 Following MOMP or mPT, a number of pro-apoptotic factors that are normally confined to the mitochondrial intermembrane or intracristae space are released, including cytochrome c (cyt c), apoptosis-inducing factor (AIF), endonuclease G (EndoG), Smac/ DIABLO and Omi/HtrA2. In this review we discuss recent emerging evidences that these two functions of mitochondriabioenergetics and cell death execution-are interlinked. We describe the roles that cyt c, AIF, EndoG, Smac/DIABLO and Omi/HtrA2, as well as proteins of the Bcl-2 family, may play in the physiological regulation of mitochondrial bioenergetics, ROS production and ion homeostasis, thus highlighting their important biological activities in addition to their role in cell death execution. CYTOCHROME C Cyt c is the only protein involved in apoptosis that was originally identified for its role in mitochondrial bioenergetics. The presence of cyt c within the mitochondrial intermembrane space is essential for synthesis of ATP by OXPHOS. Complexes I (NADH:ubiquinone oxidoreductase) and II (succinate dehydrogenase) of the ETC are fueled by the respective substrates NADH and FADH 2 , which are generated by the tricarboxylic acid cycle within the mitochondrial matrix. Electrons donated by these fuels are passed to complex III (cytochrome bc 1 complex) via ubiquinone. Cyt c accepts a single electron from complex III and carries it to complex IV (cyt c oxidase), in the rate-limiting step of the ETC. Using four electrons, complex IV reduces oxygen to water, and the flux of electrons through complexes I, III and IV of the chain drives the pumping of protons across the mitochondrial inner membrane by these complexes. 45 The activity of ATP synthase (complex V) is driven by proton influx into the matrix, and thus requires an intact Dcm to function normally. The importance of cyt c in shuttling electrons from complex III to complex IV during respiration is emphasized by the observation that cyt c knockout mice die in utero by midgestation. 46 Along with this classically defined vital role in respiration, the presence of cyt c has also recently been shown to be required for normal expression and assembly of mitochondrial ETC complexes I and IV. 47 Following the occurrence of MOMP, cyt c is released from the intermembrane space and binds to Apaf-1 and dATP. [48] [49] [50] This initiates formation of the apoptosome complex, which activates caspase 9 and triggers the caspase cascade ( Figure 2 ). The requirement for cyt c for apoptosis was examined by generating mice that express a mutant form of cyt c that could retain normal electron transfer function but could not activate Apaf-1. 51 These mice display embryonic lethality and brain developmental defects to a similar extent as those observed in mice lacking Apaf-1, 52 or caspase 9, 53 indicating that the role of cyt c in apoptosis is crucial in tissue development and homeostasis. After MOMP, the level of cyt c that is available to the mitochondrial respiration machinery is severely reduced and electron transport through the complexes is impaired, resulting in a collapse in the proton gradient across the mitochondrial inner membrane. [54] [55] [56] [57] Under these conditions, the contribution of mitochondria to intracellular ion homeostasis is lost and ATP synthase activity often reverses in order to maintain mitochondrial integrity, so that mitochondria may consume rather than generate ATP. 57, 58 MOMP-induced cyt c release therefore also induces a bioenergetic crisis that may play a role in caspaseindependent cell death. 17 However, recent studies showed that under conditions of high glycolytic activity and/or sufficient remnant cyt c available for respiration, mitochondria within cancer cells are capable of maintaining Dcm with ATP synthase working in the forward mode, with Dcm being maintained at pre-MOMP levels. 54, 59 APOPTOSIS-INDUCING FACTOR AIF was identified in 1996 as a protein normally localized within the mitochondrial intermembrane space that is released following mitochondrial permeability transition.
60,61 AIF possesses three domains: an amino-terminal presequence that is removed upon import into the intermembrane space of mitochondria, a spacer sequence and an oxidoreductase domain. 62 Upon initiation of MOMP, AIF translocates to the nucleus where it acts as a death effector, causing chromatin condensation and DNA fragmentation. 63 Although the nuclease targets of AIF remain undiscovered, there is convincing evidence to suggest that following localization to the nucleus, cells subsequently undergo caspase-independent apoptosis. 64 Homozygous AIF knockout mice do not survive past embryonic day 12, and abnormal cell death occurs as early as embryonic day 9.
65 Thus, tissue-specific AIF knockout mice have been developed to investigate the role of AIF in mitochondrial physiology. Inactivated AIF in cardiac and skeletal muscle resulted in decreased ETC complex I activity related to a reduction in protein expression, was related to severe dilated cardiomyopathy and skeletal muscle atrophy. 66 Harlequin (Hq) mice display an 80% decrease in AIF expression and were generated by a retroviral insertion into the first intron of the AIF gene. 67 Both Hq/Y males and Hq/Hq females survive until adulthood but display progressive degeneration of terminally differentiated cerebellar and retinal neurons, resulting in ataxia and blindness. 67 Expression of a mitochondrially anchored version of AIF was sufficient to rescue mitochondrial defects and enhance survival of AIF knockout neurons. 68 Taken together, these data indicate that the presence of AIF is essential for OXPHOS in cells that rely heavily on respiration. In HeLa cells, the expression of complex I subunits was diminished following AIF ablation, and the associated 40-50% decrease in complex I activity resulted in a reduction in the rate of OXPHOS and consequent increase in dependence on glycolysis. 63 Although the role of AIF in OXPHOS is still not completely understood, AIF is known to bind flavin adenine dinucleotide and has NADH oxidase activity. 69 Sensitivity to oxidative stress is increased in AIF-deficient neurons and cardiomyocytes, 67, 70 and a role for AIF as an antioxidant that protects the ETC from oxidative stress has also been proposed. 71 However, ROS production in isolated mitochondria from Hq mice oxidizing complex I substrates was no different from mitochondria isolated from wild type mice, 72 and the mechanism by which AIF ameliorates the damaging effects of oxidative stress remains unclear.
ENDONUCLEASE G
Although encoded entirely by nuclear DNA, EndoG normally resides within mitochondria, and there is evidence to indicate that it is localized within the intermembrane space 73 and also binds to the inner membrane. 74 A 5-kDa section of the 32-kDa inactive propeptide targets the protein to mitochondria, and is subsequently cleaved off. The mature 27-kDa EndoG is released following MOMP and can initiate oligonucleosomal DNA fragmentation upon translocation to the nucleus. 75 EndoG-induced apoptosis can occur independently of caspase activity 76 and depletion of EndoG can protect from a range of injury stimuli both in vivo 77 and in vitro. [78] [79] [80] A recent study elegantly identified a novel role for EndoG as a regulator of mitochondrial mass and function in cardiac tissue. 81 EndoG was shown to control the expression of mitochondrial mass, with diminished levels of both mitochondrial DNA (mtDNA) and protein in isolated heart mitochondria from Endog À / À mice compared with wild-type (WT) mice, whereas overexpression of EndoG increased mitochondrial protein and mass in vitro. In addition, respiration rates were decreased in isolated heart mitochondria from Endog À / À mice compared with WT, fueled by either complex I-or complex II-related substrates, and the rate of ROS production was increased. Among the genes identified to be regulated by EndoG were those controlling ETC enzyme expression, including subunits of complexes I (ND1 and ND2), IV (COX2) and V (ATPase6). EndoG has also been shown to cleave RNA and is capable of generating RNA primers required by DNA polymerase-g to initiate replication of mtDNA. 82 Although expressed in many cancer cells, the role of EndoG in cancer metabolism has been underexplored and warrants further investigation.
Omi STRESS-REGULATED ENDOPROTEASE/HTRA2 (Omi)
Omi is a serine protease normally located within the mitochondrial intermembrane space. The 49-kDa mtDNA-encoded proenzyme includes a mitochondrial localizing sequence that is cleaved off within the intermembrane space to expose an inhibitor of apoptosis protein (IAP)-binding motif. 83 Following MOMP, Omi is released into the cytoplasm and contributes apoptosis, by cleaving both IAPs 84 and cytoskeletal proteins. 85 Thus, Omi contributes to apoptosis in both caspase-dependent and -independent mechanisms.
A number of links between Omi function and mitochondrial dysfunction-related chronic neurodegeneration have been identified. Mnd2 (motor neuron degeneration 2) mice, which exhibit early-onset neurodegeneration associated with parkinsonism and juvenile lethality, were found to contain a loss-of-function mutation in omi, 86 indicating that omi is required for protection against stress stimuli in striatal neurons. In addition, mnd2 mice displayed reduced body weight, and organs including heart, thymus and spleen were found to be reduced in size. 86 Targeted deletion of omi in mice confirmed these findings. 87 Mutation screening of the omi gene in Parkinson's disease patients uncovered two loss-of-function mutations in single nucleotides (A141S and G399S), which were related to disease pathogenesis. 88 Overexpression of the mutated enzymes in cancer cells caused changes to mitochondrial morphology, depolarization of Dcm and sensitized the cells to staurosporine-induced apoptosis. 88 Challenging mitochondria isolated from mnd2 mouse embryonic fibroblasts with Ca 2 þ revealed that susceptibility to permeabilization was increased in the absence of active Omi compared with mitochondria isolated from WT mouse embryonic fibroblasts. 86 These data suggest that Omi plays a role in mitochondrial Ca 2 þ sequestering and mitochondrial dysfunction. In contrast, ETC enzyme activities were not reduced in omi-deficient cells. 87 Thus, the exact function of Omi in normal mitochondrial physiology remains unclear.
Smac/DIABLO Second mitochondria-derived activator of caspase (Smac) was discovered as a protein normally localized to mitochondria and released during apoptosis, promoting caspase activation by binding to and sequestering the activity of IAPs, thus relieving them of their caspase-binding partners, and sensitizing cells to apoptosis. 89 The human ortholog, named direct IAP-binding protein with a low pI (DIABLO), was simultaneously and independently identified. 90 Immature Smac/DIABLO is encoded entirely within the nuclear genome and contains a mitochondrial-localizing sequence, the cleavage of which is required to expose the IAP-binding domain. 89 The mature 23-kDa protein resides within the intermembrane space and is only released upon induction of MOMP, where it homodimerizes and inhibits various IAPs, including X-linked IAP and cellular IAPs 1 and 2.
91 Smac/DIABLO-deficient mice were shown to be viable and mature normally with no obvious histological abnormalities alterations, and Smac/DIABLO-deficient cells responded normally to multiple apoptotic stimuli. 92 However, a recent study has identified a heterozygous Smac/DIABLO mutation that was related to a progressive hearing loss disorder. 93 Overexpression of the mutant Smac/DIABLO increased mitochondrial sensitivity to Ca 2 þ , as measured by depolarization of Dcm in intact cells in the presence of the Ca 2 þ ionophore A23187. Smac is retained as a dimer within mitochondria in X-linked IAP-overexpressing breast and colon cancer cells during the process of MOMP, 94 suggesting that the protective effects of X-linked IAP may also be associated with preservation of mitochondrial function.
Bax
Bax plays a central role in the execution of mitochondrial apoptosis. In healthy cells, the majority of Bax molecules are located within the cytosol, with only a small fraction localized to mitochondria. 95 Upon induction of apoptosis, Bax undergoes a conformational activation whereby it translocates to mitochondria and aggregates, contributing to pore formation. 96 Bax may also mediate mPT-induced cell death, as double knockout of Bax and Bak protected against treatment with the Ca 2 þ ionophore ionomycin in mouse embryonic fibroblasts. 97 Interestingly, reconstitution of an oligomerization-deficient Bax mutant was sufficient to restore mPT-induced cell death, but not MOMPmediated apoptosis, suggesting that Bax oligomerization is not required for mPT. 97 Bax has been shown to have roles in normal cell physiology, including Ca 2 þ homeostasis 98 and mitochondrial dynamics. 99 Results in a recent study indicate that Bax contributes to mitochondrial ATP production in non-apoptotic cells. Although only 7% of total endogenous Bax was found to be associated with mitochondria in colorectal cancer-derived bax þ / þ HCT 116 cells, both ATP level and the oxygen consumption rate were shown to be reduced in corresponding bax À / À cells. 100 Similar results were found in nontransformed primary hepatocytes from bax knockout mice compared with those from WT animals. Interestingly, citrate synthase activity was also found to be reduced in bax-deficient cells, and the rate of glycolysis was increased, confirming that the bioenergetic deficiencies were of mitochondrial origin. Moreover, reintroduction of Bax into knockout cells was sufficient to reverse the bioenergetic deficiencies. The authors concluded that such a role for Bax in mitochondrial bioenergetics is supported by the observation that complete mutational inactivation (or deletion) of Bax is rarely found in cancers, whereas mutations that prevent the pro-apoptotic activity of Bax are relatively frequent. 100 Bcl-2 The bcl-2 was initially identified as a gene excessively transcribed in human B-cell follicular lymphoma. 101 The Bcl-2 protein can prevent initiation of mitochondrial apoptosis by binding both Bax and Bak at the mitochondrial outer membrane, inhibiting Bax/Bak oligomerization, and can also interact with VDAC, thus inhibiting pore formation. 102 Bcl-2 also has anti-apoptotic properties due to its ability to antagonize BH3-only activators Bim and Bid and sensitizers including Puma, Bad and Bik. 16, 21 Bcl-2 is thought to localize to the membranes of multiple organelles in nonapoptotic cells, including both mitochondrial inner and outer membranes, the ER membrane and the nuclear outer membrane. 103 The anti-apoptotic properties of Bcl-2 have been extensively studied, but recent evidence indicates that Bcl-2 can also directly mediate the rate of OXPHOS by interaction with mitochondrial ETC complex IV.
14,104-106 Overexpression of Bcl-2 increased O 2 À within mitochondria, interpreted as an increase in the rate of electron flow through the respiratory chain, and both isolated mitochondrial respiration rate and complex IV activity were also found to be increased in Bcl-2-overexpressing tumor cells. 104 The Va subunit of complex IV was found to physically interact with Bcl-2, and the extent of localization of this subunit to the mitochondrial inner membrane was shown to correlate to Bcl-2 expression in cancer cell lines, offering convincing evidence that Bcl-2 controls mitochondrial bioenergetic function by influencing the activity of the rate-limiting ETC enzyme, complex IV. 105 Gene silencing of Bcl-2 expression diminished O 2 À generation and reduced inner membrane localization of both Va and Vb complex IV subunits. However, Bcl-2 did not affect the expression levels of either subunits, indicating that the effects of Bcl-2 on respiration rate and ROS production are due to the role of Bcl-2 in complex IV assembly. 105 The abilities of Bcl-2 to regulate the rates of OXPHOS and ROS production have been implicated in the promotion of survival and oncogenic signaling in cancer cells. 14 
Bcl-X L
The Bcl-x L protein is encoded by the bcl-x gene, which can be alternatively spliced to produce two mRNA isoforms, Bcl-x L and Bcl-x S . 107 Expression of bcl-x is required for embryonic development, as evidenced by the observation that bcl-x knockout mice do not survive past embryonic day 13.
108
Histological analysis revealed excessive neuronal and liver hematopoietic cell apoptosis in the knockout embryos, implicating bcl-x in the development of these systems. 108 It was initially observed that Bcl-x L was similar in size and structure to Bcl-2, and accordingly was also found to have anti-apoptotic properties, with overexpression protecting against growth factor withdrawal to a similar extent as Bcl-2 overexpression. 107 Numerous Bcl-x L -binding partners have also been identified with roles in mitochondrial metabolite exchange 109 and dynamics 110 as well as autophagy signaling 111 and neuronal synaptic transmission. 112 Using a Bcl-x L conditional knockout model in primary neurons, two research groups recently jointly demonstrated a direct involvement of Bcl-x L in mitochondrial bioenergetics. 113, 114 Mitochondrial membrane potential was found to be hyperpolarized in bcl-x-deficient neurons, NAD(P)H levels were increased and ROS production was decreased. 114 In contrast to the reported localization of endogenous Bcl-x L as cytosolic homodimers in non-apoptotic HeLa cells, 115 the majority of neuronal Bcl-x L was found to be localized within mitochondria. Furthermore, 450% of the mitochondrial fraction was shown to be localized to the mitochondrial inner membrane and/or matrix by electron microscopy. 114 This study also reported that Bcl-x L directly interacts with the b-subunit of mitochondrial ETC complex V (ATP synthase) to stabilize Dcm, as bcl-x deficiency and inhibition of Bcl-x L with the chemotherapeutic agent ABT-737 both caused rapid fluctuations of Dcm in neurons. 114 In a separate study, Bcl-x L overexpression was found to increase ATP levels in primary neurons, whereas knockdown of Bcl-x L or inhibition with ABT-737 depleted ATP without affecting cell death. 113 Interestingly, the level of lactate production in cells overexpressing Bcl-x L was reduced compared with control neurons, suggesting a reduction in glycolytic rate in cells overexpressing Bcl-x L . This indicates that the Bcl-x L -induced increase in ATP occurred as a result of enhanced mitochondrial activity. However, oxygen consumption was unexpectedly found to be decreased in Bcl-x L -overexpressing neurons, and knockdown or inhibition of Bcl-x L increased oxygen uptake compared with control neurons. 113 Together, these data suggest that depletion of endogenous Bcl-x L partially uncouples OXPHOS, and it was concluded that Bcl-x L functions to bolster mitochondrial energy capacity by preventing energy wastage by futile ion flux across in mitochondrial inner membrane. 114 
Mcl-1
Mcl-1 is an anti-apoptotic Bcl-2 family member that is required for the survival of a variety of adult cell types, such as hematopoietic stem cells, 116 lymphocytes 117 and neurons. 118 Mcl-1 is essential for development of the embryo, and Mcl-1 knockout mouse embryos die peri-implantation. 119 Amplification of MCL-1 has been found to occur in numerous cancer types, including lung, breast, gastrointestinal and sarcomas. 120 The level of Mcl-1 expression at diagnosis was found to be related to disease severity in multiple myeloma, with the highest amounts corresponding to shortest event-free survival times 121 and Mcl-1 also contributes to glucocorticoid resistance in acute lymphoblastic leukemia. 122 Interestingly, although Mcl-1 deletion was found to be lethal peri-implantation, there was no difference in the percentage of apoptotic cells in Mcl-1-null blastocysts compared with WT, hinting at the existence of an essential function for Mcl-1 other than the canonical anti-apoptotic role. 119 A recent study demonstrated that Mcl-1 contains a mitochondrial targeting sequence, and the protein undergoes proteolytic cleavage giving rise to different Mcl-1 species that are localized to subcompartments within mitochondria. 123 A 40-K relativemolecular-mass (M r ) form is localized to the outer leaflet of the mitochondrial outer membrane and binds pro-apoptotic BH3-only proteins such as bim, whereas the 36-K M r form associates with the mitochondrial inner membrane and has no ability to prevent apoptosis. 123 Enzyme activities of ETC complexes I, II and IV were all reduced in mouse liver mitochondria with MCL-1 deletion, suggesting that Mcl-1 is required for normal respiration. 123 Changes in mitochondrial morphology and fusion were found upon MCL-1 deletion, and the mtDNA content was reduced, leading to decreased expression of the subunits of complex IV encoded by mtDNA (Cox 1 and Cox 2). 123 MCL-1 deletion also disrupted the organization of ETC enzymes into supercomplexes and diminished ATP synthase oligomerization, an important process in mitochondrial cristae formation. 123, 124 Thus, the 36-K M r form of Mcl-1 required for mitochondrial function may represent a novel therapeutic target in numerous types of cancer.
CONCLUSION
It is widely accepted that mitochondria originated from an ancient eubacterial ancestor, which was incorporated into eukaryotic cells. Since this time, the mitochondrial genome is known to have undergone a streamlining process whereby the current coding capacity is vastly reduced compared with that of their closest eubacterial relatives. 125 In this respect, it is perhaps unsurprising that nuclear-encoded proteins fulfil some of the bioenergetic requirements of mitochondria. Undoubtedly, eukaryotic cells are constantly subjected to a similar level of reductive evolution, leading to the expression of proteins with multiple functions. Indeed, in attempting to understand various aspects of cell physiology, researchers attribute labels (such as 'bioenergetics' and 'apoptosis') to envisage intracellular phenomena. However, evolution has no obligation to obey such labels. Hence, most of the proteins involved in mitochondrial apoptosis signaling have been discovered because of their functions in cell death, and often bear names to reflect these functions, but it is becoming increasingly evident that some-if not most-of these proteins also have important roles in mitochondrial bioenergetics in nonapoptotic cells (Figure 3) . Indeed, these proteins have also been shown to contribute to vital functions related to other intracellular processes. 126 Many of the roles have become evident because of the physiological consequences of gene mutation or deletion, resulting in various pathological phenotypes where specific tissue types were affected. This highlights not only the differences in contribution of mitochondrial bioenergetics to cell viability between tissue types, but also the heterogeneity of the mitochondria themselves. Predictably, the effects of gene deficiency in mitochondrial 'apoptosis' proteins primarily affect excitable tissues that have a high energy demand and rely on OXPHOS as the primary means of energy metabolism.
Importantly, irregularities in energy metabolism are also a common feature of a wide range of cancer types, with many forms of tumor cells capable of adapting to conditions of hypoxia and ischemia. Increased expression levels of anti-apoptotic proteins including Bcl-2, Mcl-1 and Bcl-x L are also commonly reported in various types of cancer. 127, 128 Such increased expression can prevent mitochondrial amplification of apoptosis signaling, but may also facilitate mitochondrial bioenergetic function, thus promoting survival by at least both of these mechanisms. In many cases, the details of how apoptotic proteins affect mitochondrial physiology in cancer cells remain to be elucidated, and the likelihood that further functions of 'apoptotic' proteins in non-apoptotic cellular bioenergetic function will be discovered cannot be disregarded. Electron flux through complexes I, III and IV allow them to pump protons out, creating an electrochemical gradient across the inner membrane, thus generating Dcm. Protons re-enter through complex V, generating ATP. Mitochondria rely on Dcm to import Ca 2 þ into the matrix, particularly important in excitable cells. Conversely, an increase in Ca 2 þ within the matrix can increase the rate of mitochondrial energy metabolism. AIF has NADH oxidase activity and controls expression of complex I subunits in neuronal mitochondria. Although there is no known physical interaction between EndoG and ETC enzymes, EndoG regulates mitochondrial mass and expression of subunits from complexes I, IV and V in cardiomyocytes. Cytochrome c is required by the respiratory chain of all mitochondria to carry electrons from complex III to complex IV. Mcl-1 is required for normal expression of complex IV subunits Cox 1 and Cox 2, and Bcl-2 directly interacts with the Va subunit of complex IV, facilitating assembly and electron flow. Bcl-x L directly interacts with the b-subunit of mitochondrial ETC complex V to regulate ion flux across the inner membrane. The presence of Bax within mitochondria can positively influence the rate of OXPHOS by unknown means. Omi contributes to Ca 2 þ sequestering capacity in striatal neuron mitochondria among others, as does Smac in inner ear cell mitochondria, although the exact mechanisms of interaction of both with the mitochondrial bioenergetic machinery remain unclear.
